Congressman Tom Kean, representing New Jersey’s 7th district since 2023, has been active in discussing various issues through his social media platform. On May 21, 2025, he addressed topics ranging from global health programs to the role of artificial intelligence in commerce.
In a tweet posted on May 21, Congressman Kean emphasized the importance of transparency and focus in global health initiatives led by the State Department. He stated, “We must ensure global health programs within the @StateDept are transparent, targeted, and focused on delivering life-saving care where it’s needed most.” He also highlighted New Jersey companies’ contributions to HIV treatments and diagnostics for the PEPFAR program.
Later that day, Congressman Kean shared insights from a meeting with William Lewis, CEO and Chairman of Insmed. He tweeted at 20:18 UTC about their discussion: “It was great to sit down with constituent William Lewis, CEO and Chairman of Insmed…” He praised Insmed’s efforts in developing therapies for serious and rare diseases.
In another tweet at 20:34 UTC on the same day, Congressman Kean discussed the impact of artificial intelligence on global commerce. During a House Commerce Subcommittee hearing, he engaged with witnesses regarding AI’s potential. His post read: “Artificial intelligence (AI) is set to revolutionize global commerce…”
Thomas Kean Jr., who succeeded Tom Malinowski in Congress in 2023, has previously served in both the New Jersey General Assembly and Senate. Born in Livingston in 1968 and currently residing in Westfield, Kean is an alumnus of Dartmouth College.
